Drug Shortage Report for PMS-AZITHROMYCIN
Report ID | 177747 |
Drug Identification Number | 02261634 |
Brand name | PMS-AZITHROMYCIN |
Common or Proper name | AZITHROMYCIN |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | AZITHROMYCIN |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 6 |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-12-19 |
Actual start date | |
Estimated end date | 2023-03-20 |
Actual end date | 2023-03-22 |
Shortage status | Resolved |
Updated date | 2023-03-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-12-09 | English | Compare |
v2 | 2022-12-09 | French | Compare |
v3 | 2022-12-20 | English | Compare |
v4 | 2023-02-20 | English | Compare |
v5 | 2023-02-20 | French | Compare |
v6 | 2023-03-08 | English | Compare |
v7 | 2023-03-08 | French | Compare |
v8 | 2023-03-24 | English | Compare |
v9 | 2023-03-24 | French | Compare |
Showing 1 to 9 of 9